Why the Earnings Surprise Streak Could Continue for Supernus (SUPN)Zacks Investment Research • 02/09/22
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender OfferGlobeNewsWire • 11/23/21
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/04/21
Supernus Pharmaceuticals (SUPN) Q3 Earnings and Revenues Beat EstimatesZacks Investment Research • 11/03/21
Supernus to Announce Third Quarter 2021 Financial Results and Host Conference Call on November 3, 2021GlobeNewsWire • 10/27/21
Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product PortfolioGlobeNewsWire • 10/11/21
Supernus Announces Qelbree™ sNDA for Adult Indication Accepted for Review by FDAGlobeNewsWire • 09/02/21
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/05/21
Supernus Pharmaceuticals (SUPN) Beats Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/04/21